Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-05-31

FDA Approved: CLINDAMYCIN IN 5 PERCENT DEXTROSE — Original Application (Sandoz Inc)

View source ↗

Summary

The FDA approved an Original Application for a generic clindamycin in 5% dextrose injection by Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLINDAMYCIN IN 5 PERCENT DEXTROSE (clindamycin in 5% dextrose)

Snippet

ORIG AP for CLINDAMYCIN IN 5 PERCENT DEXTROSE (CLINDAMYCIN IN 5 PERCENT DEXTROSE)